Datasets:
SKT27182
/
NER_processed_data

Dataset card Viewer Files Community
1
id
stringlengths
11
11
tags
stringlengths
10
777
text
stringlengths
2
1.5k
dataset_num
int64
1
3
tokens
sequence
ner_tags
sequence
NCT02351544
70:77:treatment,79:102:chronic_disease,117:134:chronic_disease
Patients with systemic conditions that make them poor candidates for surgery (coronary artery disease, uncontrolled diabetes mellitus, etc…)
1
[ "Patients", "with", "systemic", "conditions", "that", "make", "them", "poor", "candidates", "for", "surgery", "(", "coronary", "artery", "disease", ",", "uncontrolled", "diabetes", "mellitus", ",", "etc…", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 2, 2, 2, 0, 0, 2, 2, 0, 0, 0 ]
NCT00670358
5:22:chronic_disease
Not immunocompromised
1
[ "Not", "immunocompromised" ]
[ 0, 2 ]
NCT02451423
,,16:26:chronic_disease
CTCAE Gr >/= 2 neuropathy
1
[ "CTCAE", "Gr", ">", "/=", "2", "neuropathy" ]
[ 0, 0, 0, 0, 0, 2 ]
NCT01572480
5:8:cancer
IgA SMM
1
[ "IgA", "SMM" ]
[ 0, 3 ]
NCT02584647
8:24:treatment,33:45:treatment,49:65:treatment
Strong CYP3A inhibitors such as ketoconazole or grapefruit juice are not permitted
1
[ "Strong", "CYP3A", "inhibitors", "such", "as", "ketoconazole", "or", "grapefruit", "juice", "are", "not", "permitted" ]
[ 0, 1, 1, 0, 0, 1, 0, 1, 1, 0, 0, 0 ]
NCT01659203
27:44:allergy_name
History of sensitivity to radiation therapy
1
[ "History", "of", "sensitivity", "to", "radiation", "therapy" ]
[ 0, 0, 0, 0, 4, 4 ]
NCT02383927
,,25:35:chronic_disease
Non-tolerable > Grade 2 neuropathy
1
[ "Non-tolerable", ">", "Grade", "2", "neuropathy" ]
[ 0, 0, 0, 0, 2 ]
NCT01389024
,24:27:treatment,24:35:treatment,,,72:93:treatment,
History of two or more TCD studies with a velocity ≥ 200 cm/sec by the non-imaging technique, or ≥185 cm/sec for the imaging technique or a indeterminate TCD
1
[ "History", "of", "two", "or", "more", "TCD", "studies", "with", "a", "velocity", "≥", "200", "cm/sec", "by", "the", "non-imaging", "technique", ",", "or", "≥185", "cm/sec", "for", "the", "imaging", "technique", "or", "a", "indeterminate", "TCD" ]
[ 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02150967
11:25:treatment
selective FGFR inhibitor (Cohorts 1 and 2 only)
1
[ "selective", "FGFR", "inhibitor", "(", "Cohorts", "1", "and", "2", "only", ")" ]
[ 0, 1, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT02329327
1:15:chronic_disease
Acute bleeding in a critical area or organ such as intraspinal, pericardial, or intracranial
1
[ "Acute", "bleeding", "in", "a", "critical", "area", "or", "organ", "such", "as", "intraspinal", ",", "pericardial", ",", "or", "intracranial" ]
[ 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02527421
15:24:chronic_disease,,
Subjects with psoriasis involving ≥ 10% BSA
1
[ "Subjects", "with", "psoriasis", "involving", "≥", "10", "%", "BSA" ]
[ 0, 0, 2, 0, 0, 0, 0, 0 ]
NCT02339922
,65:74:treatment
Male patients, even if surgically sterilized (i.e., status post-vasectomy), must agree to one of the following
1
[ "Male", "patients", ",", "even", "if", "surgically", "sterilized", "(", "i.e.", ",", "status", "post-vasectomy", ")", ",", "must", "agree", "to", "one", "of", "the", "following" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02877134
,,,,177:188:treatment,219:228:chronic_disease,,337:347:cancer
A participant who has had extensive colitis for greater than or equal to (>=) 8 years, or disease limited to the left side of the colon for >= 12 years, must either have had a colonoscopy to assess for the presence of dysplasia within 1 year before the first administration of study agent or a colonoscopy to assess for the presence of malignancy at the screening visit, with no evidence of malignancy
1
[ "A", "participant", "who", "has", "had", "extensive", "colitis", "for", "greater", "than", "or", "equal", "to", "(", ">", "=", ")", "8", "years", ",", "or", "disease", "limited", "to", "the", "left", "side", "of", "the", "colon", "for", ">", "=", "12", "years", ",", "must", "either", "have", "had", "a", "colonoscopy", "to", "assess", "for", "the", "presence", "of", "dysplasia", "within", "1", "year", "before", "the", "first", "administration", "of", "study", "agent", "or", "a", "colonoscopy", "to", "assess", "for", "the", "presence", "of", "malignancy", "at", "the", "screening", "visit", ",", "with", "no", "evidence", "of", "malignancy" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01554371
20:35:treatment
Concomitant use of bisphosphonates
1
[ "Concomitant", "use", "of", "bisphosphonates" ]
[ 0, 0, 0, 1 ]
NCT02979366
11:31:chronic_disease
active or chronic pancreatitis
1
[ "active", "or", "chronic", "pancreatitis" ]
[ 0, 0, 2, 2 ]
NCT02923921
32:70:chronic_disease,79:97:chronic_disease,99:113:chronic_disease,117:147:chronic_disease
Participants with a history of immune-mediated neurological disorders such as multiple sclerosis, Guillain-Barré or inflammatory CNS/PNS disorders
1
[ "Participants", "with", "a", "history", "of", "immune-mediated", "neurological", "disorders", "such", "as", "multiple", "sclerosis", ",", "Guillain-Barré", "or", "inflammatory", "CNS/PNS", "disorders" ]
[ 0, 0, 0, 0, 0, 2, 2, 2, 0, 0, 2, 2, 0, 2, 0, 2, 2, 2 ]
NCT02538198
15:27:treatment,55:62:treatment,,255:275:treatment
Refractory to lenalidomide in the most recent line of therapy, as defined by the International Myeloma Consensus Panel criteria [47]- as failure to achieve minimal response or development of progressive disease while on lenalidomide or within 30 days of lenalidomide therapy
1
[ "Refractory", "to", "lenalidomide", "in", "the", "most", "recent", "line", "of", "therapy", ",", "as", "defined", "by", "the", "International", "Myeloma", "Consensus", "Panel", "criteria", "[", "47", "]", "-", "as", "failure", "to", "achieve", "minimal", "response", "or", "development", "of", "progressive", "disease", "while", "on", "lenalidomide", "or", "within", "30", "days", "of", "lenalidomide", "therapy" ]
[ 0, 0, 1, 1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02837510
5:20:chronic_disease
any Axis 1 disorder
1
[ "any", "Axis", "1", "disorder" ]
[ 0, 2, 2, 2 ]
NCT02544880
29:34:cancer
Recurrent or second primary HNSCC arises within the previously irradiated field
1
[ "Recurrent", "or", "second", "primary", "HNSCC", "arises", "within", "the", "previously", "irradiated", "field" ]
[ 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0 ]
NCT03143894
1:11:chronic_disease,15:22:chronic_disease,52:77:treatment,82:92:chronic_disease,
Depression or anxiety as defined either by ongoing pharmacological treatment for depression or anxiety or a HADS score on initial screening
1
[ "Depression", "or", "anxiety", "as", "defined", "either", "by", "ongoing", "pharmacological", "treatment", "for", "depression", "or", "anxiety", "or", "a", "HADS", "score", "on", "initial", "screening" ]
[ 2, 0, 2, 0, 0, 0, 0, 0, 1, 1, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03088033
,,,107:135:chronic_disease,128:135:chronic_disease,137:146:chronic_disease,
NYHA class II with a history of > NYHA class II; OR NYHA class III, or ambulatory NYHA class IV symptoms (paroxysmal nocturnal dyspnea, orthopnea, dyspnea on mild or moderate exertion) at screening; or signs (any rales post cough, chest x-ray demonstrating pulmonary congestion,) within past 12 months
1
[ "NYHA", "class", "II", "with", "a", "history", "of", ">", "NYHA", "class", "II", ";", "OR", "NYHA", "class", "III", ",", "or", "ambulatory", "NYHA", "class", "IV", "symptoms", "(", "paroxysmal", "nocturnal", "dyspnea", ",", "orthopnea", ",", "dyspnea", "on", "mild", "or", "moderate", "exertion", ")", "at", "screening", ";", "or", "signs", "(", "any", "rales", "post", "cough", ",", "chest", "x-ray", "demonstrating", "pulmonary", "congestion", ",", ")", "within", "past", "12", "months" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02524379
17:20:chronic_disease,,,
Non-penetrating SCI at neurologic level from C2 to C8
1
[ "Non-penetrating", "SCI", "at", "neurologic", "level", "from", "C2", "to", "C8" ]
[ 0, 2, 0, 0, 0, 0, 0, 0, 0 ]
NCT02020018
1:8:treatment
Steroid-dependent patients
1
[ "Steroid-dependent", "patients" ]
[ 1, 0 ]
NCT02977468
16:28:treatment,
Has received a live vaccine within 30 days of planned start of study therapy
1
[ "Has", "received", "a", "live", "vaccine", "within", "30", "days", "of", "planned", "start", "of", "study", "therapy" ]
[ 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02343549
,,,113:122:treatment
Participants of childbearing age must use effective contraception for at least 6 months following completion of treatment
1
[ "Participants", "of", "childbearing", "age", "must", "use", "effective", "contraception", "for", "at", "least", "6", "months", "following", "completion", "of", "treatment" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02744391
21:46:chronic_disease,48:57:chronic_disease,62:72:chronic_disease
DSM 5 non-psychotic Major Depressive Disorder, Dysthymia, or Depression Not Otherwise Specified
1
[ "DSM", "5", "non-psychotic", "Major", "Depressive", "Disorder", ",", "Dysthymia", ",", "or", "Depression", "Not", "Otherwise", "Specified" ]
[ 0, 0, 0, 2, 2, 2, 0, 2, 0, 0, 2, 0, 0, 0 ]
NCT03131960
1:27:chronic_disease,,
Severe or worse depression (Beck Depression Scale > 29)
1
[ "Severe", "or", "worse", "depression", "(", "Beck", "Depression", "Scale", ">", "29", ")" ]
[ 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0 ]
NCT03004807
1:10:chronic_disease
Dysphagia or difficulty swallowing
1
[ "Dysphagia", "or", "difficulty", "swallowing" ]
[ 2, 0, 0, 0 ]
NCT03101566
26:38:treatment,
Must not have received a live vaccine within 30 days of planned start of the study therapy
1
[ "Must", "not", "have", "received", "a", "live", "vaccine", "within", "30", "days", "of", "planned", "start", "of", "the", "study", "therapy" ]
[ 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02583893
13:37:chronic_disease
symptomatic congestive heart failure
1
[ "symptomatic", "congestive", "heart", "failure" ]
[ 0, 2, 2, 2 ]
NCT03135171
,,127:138:treatment,140:151:treatment,156:166:treatment
must use two forms of effective contraception during the duration of the trial and for minimum of 7 months after last dose of tocilizumab, trastuzumab, or pertuzumab
1
[ "must", "use", "two", "forms", "of", "effective", "contraception", "during", "the", "duration", "of", "the", "trial", "and", "for", "minimum", "of", "7", "months", "after", "last", "dose", "of", "tocilizumab", ",", "trastuzumab", ",", "or", "pertuzumab" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 1 ]
NCT03118973
1:30:treatment,36:60:treatment,62:89:treatment
Complex post-surgical anatomy e.g. Billroth type II anatomy, Roux-en-Y-gastrojejunostomy
1
[ "Complex", "post-surgical", "anatomy", "e.g", ".", "Billroth", "type", "II", "anatomy", ",", "Roux-en-Y-gastrojejunostomy" ]
[ 1, 1, 1, 0, 0, 1, 1, 1, 1, 0, 1 ]
NCT03143985
13:22:chronic_disease
Presence of aneurisms of the ascending aorta or aortic stress
1
[ "Presence", "of", "aneurisms", "of", "the", "ascending", "aorta", "or", "aortic", "stress" ]
[ 0, 0, 2, 0, 0, 0, 0, 0, 0, 0 ]
NCT02091141
32:59:treatment,41:59:treatment,52:59:treatment,75:81:cancer,98:104:cancer,218:227:treatment,284:293:treatment
Participants who have received standard first-line therapy for metastatic cancer (except for the tumors for which no first-line therapy exists) and in whom a trial of targeted therapy is considered the best available treatment option. Eligible participants should not have available therapies that will convey clinical benefit and/or are not suitable options per the treating physician's judgment
1
[ "Participants", "who", "have", "received", "standard", "first-line", "therapy", "for", "metastatic", "cancer", "(", "except", "for", "the", "tumors", "for", "which", "no", "first-line", "therapy", "exists", ")", "and", "in", "whom", "a", "trial", "of", "targeted", "therapy", "is", "considered", "the", "best", "available", "treatment", "option", ".", "Eligible", "participants", "should", "not", "have", "available", "therapies", "that", "will", "convey", "clinical", "benefit", "and/or", "are", "not", "suitable", "options", "per", "the", "treating", "physician", "'s", "judgment" ]
[ 0, 0, 0, 0, 1, 1, 1, 0, 0, 3, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02474927
1:12:chronic_disease
Neutropenia
1
[ "Neutropenia" ]
[ 2 ]
NCT02781519
8:28:treatment,,
taking estrogen supplements or oral contraceptive pills (for women)
1
[ "taking", "estrogen", "supplements", "or", "oral", "contraceptive", "pills", "(", "for", "women", ")" ]
[ 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02047474
16:39:chronic_disease,43:66:treatment,68:76:treatment,81:92:treatment,171:181:cancer
No evidence of extrapancreatic disease by cross sectional imaging, PET scan, or laparoscopy, including nodal involvement beyond the peripancreatic tissues and/or distant metastases
1
[ "No", "evidence", "of", "extrapancreatic", "disease", "by", "cross", "sectional", "imaging", ",", "PET", "scan", ",", "or", "laparoscopy", ",", "including", "nodal", "involvement", "beyond", "the", "peripancreatic", "tissues", "and/or", "distant", "metastases" ]
[ 0, 0, 0, 2, 2, 0, 1, 1, 1, 0, 1, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3 ]
NCT02403193
,,,,174:183:treatment,
Women of child-bearing potential, defined as all women physiologically capable of becoming pregnant, must use 2 highly effective methods of contraception while taking study treatment and for 90 days after the last dose of study treatment
1
[ "Women", "of", "child-bearing", "potential", ",", "defined", "as", "all", "women", "physiologically", "capable", "of", "becoming", "pregnant", ",", "must", "use", "2", "highly", "effective", "methods", "of", "contraception", "while", "taking", "study", "treatment", "and", "for", "90", "days", "after", "the", "last", "dose", "of", "study", "treatment" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02568267
7:32:chronic_disease,47:55:chronic_disease,105:116:chronic_disease
Known interstitial lung disease, interstitial fibrosis, or history of tyrosine kinase inhibitor-induced pneumonitis
1
[ "Known", "interstitial", "lung", "disease", ",", "interstitial", "fibrosis", ",", "or", "history", "of", "tyrosine", "kinase", "inhibitor-induced", "pneumonitis" ]
[ 0, 2, 2, 2, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 2 ]
NCT00799864
11:14:chronic_disease,
Must have HIV-1 plasma viral load at screening greater than equal to 500 HIV-1 ribonucleic acid (RNA) copies/mL
1
[ "Must", "have", "HIV-1", "plasma", "viral", "load", "at", "screening", "greater", "than", "equal", "to", "500", "HIV-1", "ribonucleic", "acid", "(", "RNA", ")", "copies/mL" ]
[ 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02188745
1:19:chronic_disease
pulmonary embolism
1
[ "pulmonary", "embolism" ]
[ 2, 2 ]
NCT03059355
28:38:cancer,
Have a clinical history of malignancy within 3 years
1
[ "Have", "a", "clinical", "history", "of", "malignancy", "within", "3", "years" ]
[ 0, 0, 0, 0, 0, 3, 0, 0, 0 ]
NCT02316574
22:46:treatment
Currently taking any psychotropic medications
1
[ "Currently", "taking", "any", "psychotropic", "medications" ]
[ 0, 0, 0, 1, 1 ]
NCT03116685
54:77:treatment,79:87:treatment,,154:157:treatment,198:223:treatment
Participation in any interventional study of another investigational product, biologic, device, or other agent within 60 days prior to the first dose of OC5 or not willing to forego other forms of investigational treatment during this study
1
[ "Participation", "in", "any", "interventional", "study", "of", "another", "investigational", "product", ",", "biologic", ",", "device", ",", "or", "other", "agent", "within", "60", "days", "prior", "to", "the", "first", "dose", "of", "OC5", "or", "not", "willing", "to", "forego", "other", "forms", "of", "investigational", "treatment", "during", "this", "study" ]
[ 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02891850
26:43:chronic_disease,,
Patients with underlying medical disorders with an anticipated life expectancy below 2 years
1
[ "Patients", "with", "underlying", "medical", "disorders", "with", "an", "anticipated", "life", "expectancy", "below", "2", "years" ]
[ 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01983462
12:34:chronic_disease,43:60:treatment,61:84:treatment,86:107:chronic_disease,109:115:chronic_disease,117:130:chronic_disease,,,188:202:chronic_disease,204:226:chronic_disease,244:265:treatment,267:293:chronic_disease
History of cardiovascular disease such as heart angioplasty/stent or bypass surgery, myocardial infarction, stroke, heart failure with or without left ventricular ejection fraction <40%, cardiomyopathy, valvular heart disease, cardiomyopathy, heart transplantation, Type 2 and Type 1 diabetes
1
[ "History", "of", "cardiovascular", "disease", "such", "as", "heart", "angioplasty/stent", "or", "bypass", "surgery", ",", "myocardial", "infarction", ",", "stroke", ",", "heart", "failure", "with", "or", "without", "left", "ventricular", "ejection", "fraction", "<", "40", "%", ",", "cardiomyopathy", ",", "valvular", "heart", "disease", ",", "cardiomyopathy", ",", "heart", "transplantation", ",", "Type", "2", "and", "Type", "1", "diabetes" ]
[ 0, 0, 2, 2, 0, 0, 1, 1, 1, 1, 1, 0, 2, 2, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 2, 2, 2, 2, 2, 2 ]
NCT02338232
17:31:treatment,33:54:treatment,59:73:treatment,88:115:treatment,200:219:treatment
Subjects taking ACE inhibitors, potassium supplements, or spironolactone (or any other potassium-sparing diuretics) who cannot discontinue use prior to initiation of study treatment OR who require a high-potassium diet
1
[ "Subjects", "taking", "ACE", "inhibitors", ",", "potassium", "supplements", ",", "or", "spironolactone", "(", "or", "any", "other", "potassium-sparing", "diuretics", ")", "who", "can", "not", "discontinue", "use", "prior", "to", "initiation", "of", "study", "treatment", "OR", "who", "require", "a", "high-potassium", "diet" ]
[ 0, 0, 1, 1, 0, 1, 1, 0, 0, 1, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT02166905
29:38:treatment
Have been informed of other treatment options
1
[ "Have", "been", "informed", "of", "other", "treatment", "options" ]
[ 0, 0, 0, 0, 0, 1, 0 ]
NCT00872950
14:25:chronic_disease
No prolonged QT syndrome as indicated by baseline EKG
1
[ "No", "prolonged", "QT", "syndrome", "as", "indicated", "by", "baseline", "EKG" ]
[ 0, 0, 2, 2, 0, 0, 0, 0, 0 ]
NCT02273375
33:42:treatment
Patients must be accessible for treatment and follow-up
1
[ "Patients", "must", "be", "accessible", "for", "treatment", "and", "follow-up" ]
[ 0, 0, 0, 0, 0, 1, 0, 0 ]
NCT01419561
33:37:chronic_disease,,
Immunohistochemical evidence of KSHV in tissues (for example by staining for LANA or vIL-6). Confirmed in the Laboratory of Pathology, CCR, NCI
1
[ "Immunohistochemical", "evidence", "of", "KSHV", "in", "tissues", "(", "for", "example", "by", "staining", "for", "LANA", "or", "vIL-6", ")", ".", "Confirmed", "in", "the", "Laboratory", "of", "Pathology", ",", "CCR", ",", "NCI" ]
[ 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03188042
21:38:allergy_name
Photosensitivity to flickering lights
1
[ "Photosensitivity", "to", "flickering", "lights" ]
[ 0, 0, 4, 4 ]
NCT02148796
1:13:chronic_disease
tuberculosis
1
[ "tuberculosis" ]
[ 2 ]
NCT02570854
20:35:chronic_disease,37:59:cancer,61:81:cancer,85:109:cancer
Known diagnosis of hemochromatosis, bone marrow malignancy, lymphatic malignancy or myelodysplastic syndrome
1
[ "Known", "diagnosis", "of", "hemochromatosis", ",", "bone", "marrow", "malignancy", ",", "lymphatic", "malignancy", "or", "myelodysplastic", "syndrome" ]
[ 0, 0, 0, 2, 0, 3, 3, 3, 0, 3, 3, 0, 3, 3 ]
NCT01925573
58:70:treatment
6 weeks since the completion of a nitrosourea-containing chemotherapy regimen
1
[ "6", "weeks", "since", "the", "completion", "of", "a", "nitrosourea-containing", "chemotherapy", "regimen" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 1, 0 ]
NCT02516969
1:37:treatment,30:37:treatment,95:101:treatment,105:115:treatment
Macroscopic complete salvage surgery with curative intent (surgery was not performed only for biopsy or palliation)
1
[ "Macroscopic", "complete", "salvage", "surgery", "with", "curative", "intent", "(", "surgery", "was", "not", "performed", "only", "for", "biopsy", "or", "palliation", ")" ]
[ 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0 ]
NCT02796391
1:21:treatment
Clopidogrel (Plavix)
1
[ "Clopidogrel", "(", "Plavix", ")" ]
[ 1, 1, 0, 0 ]
NCT02434809
16:27:cancer
Patients whose lung tumors are being monitored by MR imaging as part of standard clinical care
1
[ "Patients", "whose", "lung", "tumors", "are", "being", "monitored", "by", "MR", "imaging", "as", "part", "of", "standard", "clinical", "care" ]
[ 0, 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02741791
51:76:treatment
History of inadequate response to 1 or 2 adequate antidepressant treatments
1
[ "History", "of", "inadequate", "response", "to", "1", "or", "2", "adequate", "antidepressant", "treatments" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT02115295
26:60:treatment,65:73:treatment,75:88:treatment,94:105:treatment,107:135:treatment,137:148:treatment,150:160:treatment,162:166:treatment,,,271:284:cancer,316:343:cancer,379:392:cancer
For Frontline cohort: No prior potentially-curative therapy for leukemia. Prior therapy with hydroxyurea, hematopoietic growth factors, azacytidine, decitabine, ATRA, or a total dose of cytarabine up to 2g (for emergency use for stabilization) is allowed. Patients with secondary AMLwho have been treated for their antecedent myeloid neoplasm will be enrolled into the separate Secondary AML cohort
1
[ "For", "Frontline", "cohort", ":", "No", "prior", "potentially-curative", "therapy", "for", "leukemia", ".", "Prior", "therapy", "with", "hydroxyurea", ",", "hematopoietic", "growth", "factors", ",", "azacytidine", ",", "decitabine", ",", "ATRA", ",", "or", "a", "total", "dose", "of", "cytarabine", "up", "to", "2g", "(", "for", "emergency", "use", "for", "stabilization", ")", "is", "allowed", ".", "Patients", "with", "secondary", "AMLwho", "have", "been", "treated", "for", "their", "antecedent", "myeloid", "neoplasm", "will", "be", "enrolled", "into", "the", "separate", "Secondary", "AML", "cohort" ]
[ 0, 0, 0, 0, 0, 1, 1, 1, 0, 1, 0, 1, 1, 0, 1, 0, 1, 1, 1, 0, 1, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 0, 0, 0, 0, 0, 3, 3, 3, 0, 0, 0, 0, 0, 0, 3, 3, 0 ]
NCT01919619
4:20:chronic_disease
No active infection
1
[ "No", "active", "infection" ]
[ 0, 2, 2 ]
NCT01734512
29:71:treatment,
Patients should not receive immunization with attenuated live vaccines within one week of study entry or during study period
1
[ "Patients", "should", "not", "receive", "immunization", "with", "attenuated", "live", "vaccines", "within", "one", "week", "of", "study", "entry", "or", "during", "study", "period" ]
[ 0, 0, 0, 0, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02303977
,,109:118:treatment
Women of childbearing potential and sexually active males must use an effective contraception method during treatment and for three months after completing treatment
1
[ "Women", "of", "childbearing", "potential", "and", "sexually", "active", "males", "must", "use", "an", "effective", "contraception", "method", "during", "treatment", "and", "for", "three", "months", "after", "completing", "treatment" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT02551679
1:7:chronic_disease
Anemia
1
[ "Anemia" ]
[ 2 ]
NCT02466685
12:18:chronic_disease,20:32:cancer,33:71:chronic_disease,105:127:chronic_disease,
History of stroke, brain tumor, head trauma with loss of consciousness, or other clinically significant neurological condition within 12 months before screening
1
[ "History", "of", "stroke", ",", "brain", "tumor", ",", "head", "trauma", "with", "loss", "of", "consciousness", ",", "or", "other", "clinically", "significant", "neurological", "condition", "within", "12", "months", "before", "screening" ]
[ 0, 0, 2, 0, 3, 3, 0, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0 ]
NCT02541565
,,88:96:cancer
Absolute neutrophil count (ANC) >= 1,500/mcL except in cases of marrow infiltration by lymphoma
1
[ "Absolute", "neutrophil", "count", "(", "ANC", ")", ">", "=", "1,500/mcL", "except", "in", "cases", "of", "marrow", "infiltration", "by", "lymphoma" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3 ]
NCT03134274
6:14:chronic_disease
Have dementia
1
[ "Have", "dementia" ]
[ 0, 2 ]
NCT02665338
1:14:treatment
brain surgery
1
[ "brain", "surgery" ]
[ 1, 1 ]
NCT02392572
19:34:treatment,,103:119:treatment,,149:168:treatment
The interval from prior treatment to time of study drug administration should be at least 2 weeks for cytotoxic agents or at least 5 half-lives for noncytotoxic agents
1
[ "The", "interval", "from", "prior", "treatment", "to", "time", "of", "study", "drug", "administration", "should", "be", "at", "least", "2", "weeks", "for", "cytotoxic", "agents", "or", "at", "least", "5", "half-lives", "for", "noncytotoxic", "agents" ]
[ 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT02762006
12:41:chronic_disease
History of leptomeningeal carcinomatosis
1
[ "History", "of", "leptomeningeal", "carcinomatosis" ]
[ 0, 0, 2, 2 ]
NCT02342782
67:77:treatment
Bone marrow (BM) harvest required to reach adequate cell dose for transplant
1
[ "Bone", "marrow", "(", "BM", ")", "harvest", "required", "to", "reach", "adequate", "cell", "dose", "for", "transplant" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02394535
17:25:treatment
low dose (1 mg) Coumadin is allowed
1
[ "low", "dose", "(", "1", "mg", ")", "Coumadin", "is", "allowed" ]
[ 0, 0, 0, 0, 0, 0, 1, 0, 0 ]
NCT02472834
1:4:chronic_disease
HIV positive
1
[ "HIV", "positive" ]
[ 2, 0 ]
NCT02461927
1:7:treatment,,54:75:treatment,90:96:treatment
Opioid use within 10 days prior to study medication (injectable naltrexone) or risks for opioid use during the study
1
[ "Opioid", "use", "within", "10", "days", "prior", "to", "study", "medication", "(", "injectable", "naltrexone", ")", "or", "risks", "for", "opioid", "use", "during", "the", "study" ]
[ 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0 ]
NCT02389309
1:15:treatment,16:30:treatment,44:90:treatment,97:105:treatment,107:135:treatment
Anticoagulants/anti-platelets: patients on therapeutic (treatment) dose of anticoagulants (e.g. warfarin, low molecular-weight heparin)
1
[ "Anticoagulants/anti-platelets", ":", "patients", "on", "therapeutic", "(", "treatment", ")", "dose", "of", "anticoagulants", "(", "e.g", ".", "warfarin", ",", "low", "molecular-weight", "heparin", ")" ]
[ 1, 0, 0, 0, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 1, 0, 1, 1, 1, 0 ]
NCT02315612
15:26:chronic_disease
Subjects with CNS disease
1
[ "Subjects", "with", "CNS", "disease" ]
[ 0, 0, 2, 2 ]
NCT02120222
69:92:chronic_disease,96:111:treatment,129:167:chronic_disease,184:221:chronic_disease,222:254:chronic_disease
Uncontrolled clinically significant conduction abnormalities (e.g.: ventricular tachycardia on antiarrhythmics are excluded and 1st degree atrioventricular (AV) block or asymptomatic left anterior fascicular block [LAFB]/right bundle branch block [RBBB]
1
[ "Uncontrolled", "clinically", "significant", "conduction", "abnormalities", "(", "e.g", ".", ":", "ventricular", "tachycardia", "on", "antiarrhythmics", "are", "excluded", "and", "1st", "degree", "atrioventricular", "(", "AV", ")", "block", "or", "asymptomatic", "left", "anterior", "fascicular", "block", "[", "LAFB", "]", "/right", "bundle", "branch", "block", "[", "RBBB", "]" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 1, 0, 0, 0, 2, 2, 2, 2, 2, 0, 0, 0, 0, 2, 2, 2, 2, 2, 0, 0, 2, 2, 2, 2, 2, 0, 0 ]
NCT02254863
19:29:cancer
Active concurrent malignancy
1
[ "Active", "concurrent", "malignancy" ]
[ 0, 0, 3 ]
NCT02857270
6:51:cancer
Have symptomatic central nervous system malignancy or metastasis
1
[ "Have", "symptomatic", "central", "nervous", "system", "malignancy", "or", "metastasis" ]
[ 0, 3, 3, 3, 3, 3, 0, 0 ]
NCT01967823
1:27:chronic_disease,38:62:treatment,64:85:chronic_disease,130:147:chronic_disease
Active systemic infections requiring anti-infective treatment, coagulation disorders, or any other active or uncompensated major medical illnesses
1
[ "Active", "systemic", "infections", "requiring", "anti-infective", "treatment", ",", "coagulation", "disorders", ",", "or", "any", "other", "active", "or", "uncompensated", "major", "medical", "illnesses" ]
[ 2, 2, 2, 0, 1, 1, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2 ]
NCT02214667
7:25:chronic_disease
brief psychotic disorder
1
[ "brief", "psychotic", "disorder" ]
[ 0, 2, 2 ]
NCT03128268
1:5:treatment
ICDs implanted
1
[ "ICDs", "implanted" ]
[ 1, 0 ]
NCT02544880
7:16:treatment,39:46:treatment,54:66:treatment,117:122:cancer
Prior radiation with or without prior surgery and/or chemotherapy, to the head and neck for definitive treatment of HNSCC of the oral cavity, oropharynx, hypopharynx or larynx with previously documented complete clinical or radiographic response to initial treatment
1
[ "Prior", "radiation", "with", "or", "without", "prior", "surgery", "and/or", "chemotherapy", ",", "to", "the", "head", "and", "neck", "for", "definitive", "treatment", "of", "HNSCC", "of", "the", "oral", "cavity", ",", "oropharynx", ",", "hypopharynx", "or", "larynx", "with", "previously", "documented", "complete", "clinical", "or", "radiographic", "response", "to", "initial", "treatment" ]
[ 0, 1, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02519322
,,,72:81:treatment
White blood cells (WBC) >= 2.0 X 10^9/L (within 28 days of first study treatment)
1
[ "White", "blood", "cells", "(", "WBC", ")", ">", "=", "2.0", "X", "10^9/L", "(", "within", "28", "days", "of", "first", "study", "treatment", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0 ]
NCT02311621
19:41:cancer
Patients may have CNS intracranial tumor
1
[ "Patients", "may", "have", "CNS", "intracranial", "tumor" ]
[ 0, 0, 0, 3, 3, 3 ]
NCT02570854
23:29:treatment
Patients who received CSJ137 dose in the pas
1
[ "Patients", "who", "received", "CSJ137", "dose", "in", "the", "pas" ]
[ 0, 0, 0, 1, 0, 0, 0, 0 ]
NCT02479906
34:43:treatment
Subject is able to adhere to the treatment schedule
1
[ "Subject", "is", "able", "to", "adhere", "to", "the", "treatment", "schedule" ]
[ 0, 0, 0, 0, 0, 0, 0, 1, 0 ]
NCT01061515
41:53:treatment
All patients must be consented prior to chemotherapy
1
[ "All", "patients", "must", "be", "consented", "prior", "to", "chemotherapy" ]
[ 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT03004807
14:20:cancer,26:38:treatment,42:61:treatment,
diagnosis of cancer with chemotherapy or radiation treatment during the previous 5 years
1
[ "diagnosis", "of", "cancer", "with", "chemotherapy", "or", "radiation", "treatment", "during", "the", "previous", "5", "years" ]
[ 0, 0, 3, 0, 1, 0, 1, 1, 0, 0, 0, 0, 0 ]
NCT00632853
115:127:treatment
patients also must have met all of the eligibility criteria in the protocol prior to receiving the first cycle of chemotherapy
1
[ "patients", "also", "must", "have", "met", "all", "of", "the", "eligibility", "criteria", "in", "the", "protocol", "prior", "to", "receiving", "the", "first", "cycle", "of", "chemotherapy" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02512497
1:31:chronic_disease,,,,,158:172:treatment,180:183:treatment
Congestive heart failure (CHF) that meets New York Heart Association (NYHA) Class II to IV definitions and/or ejection fraction <40% by MUGA scan or <50% by echocardiogram and/or MRI
1
[ "Congestive", "heart", "failure", "(", "CHF", ")", "that", "meets", "New", "York", "Heart", "Association", "(", "NYHA", ")", "Class", "II", "to", "IV", "definitions", "and/or", "ejection", "fraction", "<", "40", "%", "by", "MUGA", "scan", "or", "<", "50", "%", "by", "echocardiogram", "and/or", "MRI" ]
[ 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1 ]
NCT02863991
,,,82:91:treatment
Absolute neutrophil count ≥1,000/mm3 without growth factor use ≤ 7 days prior to treatment (cycle 1 day 1, C1D1)
1
[ "Absolute", "neutrophil", "count", "≥1,000/mm3", "without", "growth", "factor", "use", "≤", "7", "days", "prior", "to", "treatment", "(", "cycle", "1", "day", "1", ",", "C1D1", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01367444
,,65:79:treatment
Reduction in macular mean sensitivity of ≥1.2 dB as assessed by microperimetry
1
[ "Reduction", "in", "macular", "mean", "sensitivity", "of", "≥1.2", "dB", "as", "assessed", "by", "microperimetry" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT01956084
7:10:chronic_disease
Donor HIV negative
1
[ "Donor", "HIV", "negative" ]
[ 0, 2, 0 ]
NCT01842399
8:17:treatment,65:84:treatment,86:106:treatment,108:129:treatment,131:150:treatment,152:170:treatment,174:210:treatment,251:262:treatment,308:321:treatment
Taking medicines that may increase the risk of bleeding such as Coumadin (warfarin), Plavix (clopidogrel), Xarelto (rivaroxaban), Pradaxa (dabgatran), Eliquis (apixaban) or Heparin (blood thinning medications) due to their potential interaction with resveratrol and the increased risk for bleeding with the muscle biopsy
1
[ "Taking", "medicines", "that", "may", "increase", "the", "risk", "of", "bleeding", "such", "as", "Coumadin", "(", "warfarin", ")", ",", "Plavix", "(", "clopidogrel", ")", ",", "Xarelto", "(", "rivaroxaban", ")", ",", "Pradaxa", "(", "dabgatran", ")", ",", "Eliquis", "(", "apixaban", ")", "or", "Heparin", "(", "blood", "thinning", "medications", ")", "due", "to", "their", "potential", "interaction", "with", "resveratrol", "and", "the", "increased", "risk", "for", "bleeding", "with", "the", "muscle", "biopsy" ]
[ 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 1, 1, 0, 0, 0, 1, 1, 0, 0, 0, 1, 1, 0, 0, 0, 1, 1, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT02807272
49:73:chronic_disease
New York Heart Association grade III or greater congestive heart failure
1
[ "New", "York", "Heart", "Association", "grade", "III", "or", "greater", "congestive", "heart", "failure" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2 ]
NCT02451553
26:37:cancer
Histologically confirmed solid tumor malignancy
1
[ "Histologically", "confirmed", "solid", "tumor", "malignancy" ]
[ 0, 0, 3, 3, 0 ]
NCT03032705
5:26:treatment,
Any restorative treatment of the teeth involved in the study in the last 12 months
1
[ "Any", "restorative", "treatment", "of", "the", "teeth", "involved", "in", "the", "study", "in", "the", "last", "12", "months" ]
[ 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01421095
1:33:treatment
pelvic or total body irradiation
1
[ "pelvic", "or", "total", "body", "irradiation" ]
[ 1, 1, 1, 1, 1 ]
NCT02589938
11:23:treatment
Receiving chemotherapy during study period
1
[ "Receiving", "chemotherapy", "during", "study", "period" ]
[ 0, 1, 0, 0, 0 ]